Search research articles
Contact Us
Filters
Showing results (211-220 of 225) with videos related to
Page
of 23
Sort By:
The Journal of Clinical Investigation
|
July 21, 2015
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Mark R Rigby, Kristina M Harris, Ashley Pinckney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2016
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman, Daniel Neiman, Hai Zemmour, et al.
Lancet (London, England)
|
April 9, 2013
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran, Brian Bundy, Dorothy J Becker, et al.
Diabetes Care
|
December 18, 2019
Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC
Rajashree Mishra, Mikael Åkerlund, Diana L Cousminer, et al.
Diabetes Care
|
November 23, 2019
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia, Simi Ahmed, Mark S Anderson, et al.
Diabetes
|
January 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes
Carla J Greenbaum, S Alice Long, Stephen E Gitelman, et al.
Pancreas
|
October 7, 2022
Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium
Phil A Hart, Georgios I Papachristou, Walter G Park, et al.
Nature Genetics
|
June 15, 2021
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes
Catherine C Robertson, Jamie R J Inshaw, Suna Onengut-Gumuscu, et al.
JCI Insight
|
November 8, 2021
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Carla J Greenbaum, Elisavet Serti, Katharina Lambert, et al.
Diabetes Care
|
September 27, 2018
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
Diana L Cousminer, Emma Ahlqvist, Rajashree Mishra, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 225) with videos related to
Sort By:
Page
of 23
The Journal of Clinical Investigation
|
July 21, 2015
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Mark R Rigby, Kristina M Harris, Ashley Pinckney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2016
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman, Daniel Neiman, Hai Zemmour, et al.
Lancet (London, England)
|
April 9, 2013
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran, Brian Bundy, Dorothy J Becker, et al.
Diabetes Care
|
December 18, 2019
Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC
Rajashree Mishra, Mikael Åkerlund, Diana L Cousminer, et al.
Diabetes Care
|
November 23, 2019
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia, Simi Ahmed, Mark S Anderson, et al.
Diabetes
|
January 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes
Carla J Greenbaum, S Alice Long, Stephen E Gitelman, et al.
Pancreas
|
October 7, 2022
Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium
Phil A Hart, Georgios I Papachristou, Walter G Park, et al.
Nature Genetics
|
June 15, 2021
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes
Catherine C Robertson, Jamie R J Inshaw, Suna Onengut-Gumuscu, et al.
JCI Insight
|
November 8, 2021
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Carla J Greenbaum, Elisavet Serti, Katharina Lambert, et al.
Diabetes Care
|
September 27, 2018
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
Diana L Cousminer, Emma Ahlqvist, Rajashree Mishra, et al.
Page
of 23